Physician

Adele Amine, DO

According to 2025 Medicare claims, Adele Amine, DO (NPI: 1891155099) practices endocrinology in the Battle Creek, MI market, with the plurality of this provider's patient population coming from Calhoun, MI. This provider's primary affiliated billing organization is BRONSON BATTLE CREEK HOSPITAL (NPI: 1093119638; TIN: 382776791) and primary practice location at 49017-3395. Amine is affiliated with the HSHS ACO, L.L.C. (ACO ID: A2783), participating under the MSSP model.

Amine's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 111 traditional Medicare patients, billed 1,780 HCPCS/CPT codes, and received $34,730 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,030 prescription claims across 213 beneficiaries totaling $441,087 in drug costs, led by Ozempic (Semaglutide). DME data shows 50 claims. Open Payments data shows 2 records totaling $233. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $445 to $441,087. For DME billing, reported payments moved sharply higher in recent years, from $659 to $15,360.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	92	733	$20,172
2022	296	5,000	$107,544
2023	113	474	$15,707
2024	111	1,780	$34,730

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	20	38	$445
2017	73	151	$9,818
2018	59	147	$10,094
2019	38	80	$15,677
2020	72	234	$85,019
2021	142	505	$202,139
2022	413	1,972	$1,095,742
2023	453	1,289	$760,644
2024	213	1,030	$441,087

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	12	$227
2022	76	193	$21,864
2023	68	211	$24,367
2024	29	50	$14,647

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	33	49	$91
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	29	29	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	66	83	$60
96372	Injection of drug or substance under skin or into muscle	13	18	$10
36415	Insertion of needle into vein for collection of blood sample	66	109	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	43	1,946	$60,275
Jardiance	Empagliflozin	45	2,834	$55,609
Levothyroxine Sodium	Levothyroxine Sodium	127	7,473	$47,640
Trulicity	Dulaglutide	30	1,235	$41,497
Rybelsus	Semaglutide	23	930	$27,433

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	18	37	$14,443
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	11	13	$204

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$233	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adele Amine, DO?

Tedicare shows public-source Medicare data for Adele Amine, DO (NPI 1891155099), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adele Amine, DO have ACO affiliation data?

Adele Amine, DO is shown with ACO affiliation data for HSHS ACO, L.L.C. (MSSP, ACO ID A2783).

What billing organization is linked to Adele Amine, DO?

Adele Amine, DO is linked to BRONSON BATTLE CREEK HOSPITAL (billing NPI 1093119638) in the available physician profile data.

Does Adele Amine, DO have Open Payments data?

Adele Amine, DO has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.